Keyphrases
Minnelide
100%
Cerebellar Toxicity
100%
Phase 1 Clinical Trial
40%
Presenting Symptoms
40%
Imaging Findings
40%
Fluid-attenuated Inversion Recovery (FLAIR)
40%
New Drugs
20%
Metastatic Cancer
20%
Gastrointestinal Malignancies
20%
Supratentorial
20%
MRI Evaluation
20%
Cerebellar Cortex
20%
Temporal Association
20%
T2-weighted Imaging (T2WI)
20%
Deep Cerebellar nuclei
20%
Restricted Diffusion
20%
Antineoplastic Agents
20%
Radiographic Patterns
20%
Cortical Involvement
20%
Pancreatic Malignancy
20%
ADC Map
20%
Radiological Manifestations
20%
Medicine and Dentistry
Magnetic Resonance Imaging
100%
Clinical Trial
66%
Anticarcinogen
33%
Cancer
33%
Metastatic Carcinoma
33%
Cerebellar Cortex
33%